Prof Ian Frazer Appointed to Scientific Advisory Board of Avantogen's Hawaii Biotech, Inc.
Avantogen Ltd welcomes Professor Ian Frazer to the Scientific Advisory Board of Hawaii Biotech Inc. (HBI), where Avantogen owns a significant portion of the total equity. Prof Frazer is an immunologist and the 2006 Australian of the Year. HBI is a privately held vaccine development company located in Honolulu, Hawaii.
Dr William Ardrey, CEO of Avantogen commented, "The addition of Prof Ian Frazer to Hawaii Biotech is a very positive development for Avantogen's shareholders. His appointment is seen as a validation of the technology platform as well as of the vaccines that are currently in clinical development at HBI. Previously, shareholders have seen progress with the US FDA and the West Nile Virus program. The Dengue program in conjunction with the Paediatric Dengue Vaccines Initiative (PDVI), funded by the Bill & Melinda Gates Foundation and Rockefeller Foundation, is also running according to schedule. We hope to deliver progress reports on these programs in the coming weeks."
Organizations
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Before retinal cells die, they regenerate, Penn vet blindness study finds
UF medicinal chemists modify sea bacteria byproduct for use as potential cancer drug
PharmaNeuroBoost’s lead product in major depression receives IND approval from FDA
WITec opens new regional headquarters in Singapore

A 'bio-refinery': using the chemistry of willow trees to treat municipal wastewater - Millions of litres of primary municipal wastewater can be treated sustainably using fast-growing willow trees while also producing renewable bioenergy and ‘green’ chemicals
Lymphoma overrides a key protein's quadruple locks
TxCell presents final positive results of the phase I/II clinical trial with antigen-specific Treg cells in Crohn’s disease
Two known chemotherapy agents effectively target breast cancer stem cells
Psilocybin eases existential anxiety in people with life-threatening cancer

Anti-cancer drug brewed from reprogrammed yeast - Engineered yeast cells can synthetically produce the essential cancer medicine vinblastine, an international team of scientists proved
